2.4. Outcome Measures
SECONDARY
Our primary outcome was to monitor therapeutic efficacy of glutathione in treating symptoms of ASD in children. Our secondary outcome was to evaluate the tolerability of oral glutathione in children with ASD. The following scales and checklists were used for the goals of the study.